EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Immunoglobulin G4-Related Disease-Associated Dermatitis with Pruritus: A Positive Response to Dupilumab

Tyler C Beck iD, John Plante, India Robinson, Katsiaryna Khatskevich, Jessica A Forcucci, Manuel Valdebran

Life · 20.03.2023 · 13 (3) · 833

DOI: 10.3390/life13030833 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Life, online erschienen am 20.03.2023. Verfasst von Tyler C Beck und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC 29425, USA. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunoglobulin G4-related disease (IgG4-RD) is a rare fibro-inflammatory condition characterized by IgG4-expressing plasma cell infiltration of the skin and other organs, leading to profound itchiness. Oral corticosteroids are the first-line therapy for IgG4-RD but relapses and potential side effects are common. In this case, we discuss a patient with a hyperpigmented, scaling dermatitis on his arms, back, and chest with lichen amyloidosis (LA) that incompletely responded to corticosteroids. He had reduced quality of life secondary to chronic pruritus. Dupilumab, an IL-4 and IL-13 inhibitor, was initiated. He experienced a transient worsening, followed by complete resolution of his itch with remission of his rash. While the pathogenesis of IgG4-RD is not entirely understood, a T-helper 2 (Th2) immune response has been implicated, with interleukins (IL) 4, 5, 10, and 13 playing a role in IgG4 class switch, resulting in eosinophilia and elevated IgE. The strong response of dupilumab in this case may provide evidence in favor of the involvement of IL-4 and IL-13 in the pathogenesis of cutaneous IgG4-RD. Future clinical studies involving larger patient populations may be warranted.

Schlagwörter

Stichwörter der Autor:innen

IgG4-related diseaseIgG4-related skin diseasebiologicdermatitisdupilumabimmunoglobulin G4-related diseaseimmunoglobulin G4-related skin diseaselichen amyloidosisprimary cutaneous amyloidosisprimary localized cutaneous amyloidosis

Autor:innen und Institutionen

  • Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC 29425, USA.
  • Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
  • Department of Pediatrics, Medical University of South Carolina, Charleston, SC 29425, USA.

ORCID-Profile: Tyler C Beck

Zitieren

APA

Beck, T. C., Plante, J., Robinson, I., Khatskevich, K., Forcucci, J. A., & Valdebran, M. (2023). Immunoglobulin G4-Related Disease-Associated Dermatitis with Pruritus: A Positive Response to Dupilumab. Life, 13(3), 833. https://doi.org/10.3390/life13030833

Vancouver

Beck TC, Plante J, Robinson I, Khatskevich K, Forcucci JA, Valdebran M. Immunoglobulin G4-Related Disease-Associated Dermatitis with Pruritus: A Positive Response to Dupilumab. Life. 2023;13(3):833. doi:10.3390/life13030833

BibTeX
@article{Beck2023,
  author = {Beck, Tyler C and Plante, John and Robinson, India and Khatskevich, Katsiaryna and Forcucci, Jessica A and Valdebran, Manuel},
  title = {Immunoglobulin G4-Related Disease-Associated Dermatitis with Pruritus: A Positive Response to Dupilumab},
  journal = {Life},
  year = {2023},
  volume = {13},
  number = {3},
  pages = {833},
  doi = {10.3390/life13030833}
}
Kostenlos starten →